rcmc semaglutide Weight loss drug may reduce alcohol cravings, heavy drinking and smoking, new study finds Metabolic Research Peptides | RCM

Aligned with earlier findings, semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from merely preventing further weight gain in Patient 1 to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3, respectively

For patients with type 2 diabetes or prediabetes, this dual benefit of weight loss and glycemic control is particularly advantageous

So this is interesting to me because what I'm trying to build towards is a greater understanding as to what the GLP-1s are actually doing that are leading people to, trying it for all sorts of other things

With the right combination of medication, nutrition, and expert advice, achieving sustainable weight loss becomes a realistic goal